TABLE 2

FENO50 and NO parameters expressed as median (upper and lower quartiles), before and after VO2max test for all subjects together as a group and also divided into nonasthma and declared asthma groups

All (n=25)Nonasthma (n=17)Asthma (n=8)
BeforeAfterp-valueBeforeAfterp-valueBeforeAfterp-value
FENO50 ppb17 (11–24)11 (7–17)<0.00117 (10–24)11 (7–18)<0.00116 (13–28)13 (8–16)0.012
JawNO nL·s−10.91 (0.60–1.57)0.63 (0.33–0.90)<0.0010.74 (0.55–1.57)0.63 (0.26–0.88)<0.0010.93 (0.68–1.67)0.69 (0.42–0.94)0.093
CawNO ppb52 (36–81)43 (31–73)0.42751 (24–64)36 (31–96)0.55464 (45–131)51 (33–59)0.036
DawNO mL·s−120 (15–25)16 (8–19)0.03221 (16–25)11 (7–18)0.00416 (8–24)19 (11–22)0.401
CANO ppb1.6 (1.1–1.9)1.9 (1.6–2.4)0.0061.5 (1.0–1.9)2.0 (1.6–2.8)0.0051.6 (1.4–2.0)1.7 (1.4–2.0)0.401

Data are presented as median (interquartile range), unless otherwise stated. FENO50: baseline exhaled nitric oxide fraction; VO2max: maximal oxygen uptake; JawNO: the airway flux of NO; CawNO: content of NO in the airway wall; DawNO: diffusing capacity of NO; CANO: alveolar NO.